[Form 4] AMERICAN EXPRESS CO Insider Trading Activity

Rhea-AI Filing Summary

American Express (AXP) reported an insider transaction by its Chief Marketing Officer under a 10b5-1 trading plan adopted on July 25, 2025. On October 31, 2025, the officer exercised 50,000 employee stock options at $65.43 per share and sold 50,000 common shares in multiple trades.

Sales were executed in tranches, including 1,083 shares at a weighted average price of $356.94, 4,971 at $358.10, 4,234 at $359.04, 15,532 at $360.09, 15,196 at $360.79, and 8,984 at $361.57. Following the transactions, the officer reported 85,576.72 shares held directly and 2,171.23 shares held indirectly via a 401(k) plan. The option related to 50,000 shares and carried an expiration date of April 29, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rutledge Elizabeth

(Last) (First) (Middle)

200 VESEY STREET, AMERICAN EXPRESS TOWER

(Street)

NEW YORK NY 10285-5001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AMERICAN EXPRESS CO [ AXP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/31/2025		M		50,000(1)	A	$65.43	135,576.72(2)	D
Common Stock	10/31/2025		S		1,083	D	$356.94(3)	134,493.72	D
Common Stock	10/31/2025		S		4,971	D	$358.1(4)	129,522.72	D
Common Stock	10/31/2025		S		4,234	D	$359.04(5)	125,288.72	D
Common Stock	10/31/2025		S		15,532	D	$360.09(6)	109,756.72	D
Common Stock	10/31/2025		S		15,196	D	$360.79(7)	94,560.72	D
Common Stock	10/31/2025		S		8,984	D	$361.57(8)	85,576.72	D
Common Stock								2,171.23	I	by 401(k) Plan(9)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$65.43	10/31/2025		M			50,000	(10)	04/29/2026	Common Stock	50,000	$0	0	D

Explanation of Responses:

1. The transactions reported on this Form 4 were effected pursuant to a 10b5-1 Trading Plan adopted by the reporting person on July 25, 2025.

2. Includes shares acquired pursuant to dividend reinvestment.

3. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $356.61 to $357.38. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

4. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $357.65 to $358.55. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

5. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $358.56 to $359.51. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

6. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $359.52 to $360.49. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

7. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $360.49 to $361.11. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

8. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $361.12 to $361.96. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

9. Shares held in reporting person's account under the Company's Retirement Savings Plan. This plan uses unit accounting, and the number of shares that a participant is deemed to hold varies with the unit price of the Company pooled stock fund.

10. The option vested in three installments based upon the satisfaction of performance criteria specified for the award at the time of grant: 60% on April 29, 2018, 20% on April 29, 2019 and 20% on April 29, 2020.

Remarks:

Exhibit 24: Power of Attorney

	/s/ James J. Killerlane III, attorney in-fact	11/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did AXP report?

The Chief Marketing Officer exercised 50,000 options at $65.43 and sold 50,000 common shares on October 31, 2025 under a 10b5-1 plan.

What were the sale prices for the AXP insider trades?

Weighted average prices per tranche ranged from $356.94 to $361.57, with underlying trade ranges from $356.61 to $361.96.

How many AXP shares does the insider hold after the trades?

Reported holdings are 85,576.72 shares directly and 2,171.23 shares indirectly via a 401(k) plan.

Was the AXP insider trading under a 10b5-1 plan?

Yes. The transactions were effected pursuant to a 10b5-1 trading plan adopted on July 25, 2025.

What were the details of the exercised AXP options?

An employee stock option covering 50,000 shares was exercised at $65.43 with an expiration date of April 29, 2026.

Who conducted the trades for AXP?

An officer of the company, serving as Chief Marketing Officer.